A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

NCT06089616 · clinicaltrials.gov ↗
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Ipsen